Anthony Barry

Anthony Barry serves as a Part-time Lecturer in the Department of Biomedical Engineering at Tufts University, a role he has maintained for 17 years while concurrently holding an executive position at Pfizer, Inc. as Executive Director and Emerging Science Lead for Biotherapeutics and Digital Technologies. With over two decades of pharmaceutical industry experience, his career bridges academic instruction and industrial therapeutic development.

His academic qualifications include:

• PhD from the University of Utah (2001)
• BA from Carleton College (1995)

Dr. Barry's research expertise focuses on innovative pharmaceutical solutions, particularly:

• Advanced drug delivery and controlled release systems
• Pharmaceutical formulation science and development
• Pharmacokinetic/pharmacodynamic modeling
• Bioprocessing techniques
• Artificial intelligence applications in drug discovery

He designed and teaches Tufts' comprehensive drug delivery course covering administration routes, biomaterials, and physiological interactions. His industry leadership at Pfizer emphasizes emerging technologies in biotherapeutics and digital health solutions.

No scientific awards were referenced in the source documentation.

While specific graduate student mentorship or research funding details remain unreported, his sustained 17-year teaching commitment demonstrates significant educational impact in biomedical engineering.